The FDA is committed to ensuring data transparency by promoting timely registration and reporting of results information to ClinicalTrials.gov.
Similar Posts
Lonza Guangzhou Pharmaceutical Ltd. | 10/31/25 | 483
Lonza Guangzhou Pharmaceutical Ltd. | 10/31/25 | 483Hello Cake, Inc. dba Hello Cake – 09/09/2025
Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetStreamlined Trials Embedded in clinical Practice (STEP) Demonstration Project
C3TI aims to promote the adoption of pragmatic design in clinical trials and improve coordination and collaboration between CDER and sponsors to effectively support these innovative trials.Apotex Inc. – 714137 – 10/31/2025
CGMP/Finished Pharmaceuticals/AdulteratedExecutive Order 14017 on America’s Supply Chains
Updates on recommendations to help shore up the U.S. pharmaceutical supply chain, as directed by Executive Order 14017 on America’s Supply ChainsMr. Strong Guy Honey For Him contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Mr. Strong Guy Honey For Him, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.